24.41
Finanzdaten der Immunovant Inc-Aktie (IMVT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
13.21%
114.36
|
131.76 | 127.22 | 115.74 | 94.28 |
| Income/Loss From Continuing Operations Before Tax |
13.36%
-109.08
|
-125.91 | -119.70 | -109.04 | -87.07 |
| Income Tax Expense/Benefit |
161.28%
1.552
|
0.594 | 0.913 | 0.078 | 0.077 |
| Income/Loss From Continuing Operations After Tax |
12.54%
-110.64
|
-126.50 | -120.61 | -109.12 | -87.15 |
|
|
12.54%
-110.64
|
-126.50 | -120.61 | -109.12 | -87.15 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4.53%
181.51
|
173.64 | 170.87 | 146.47 | 146.09 |
| Diluted Average Shares |
4.53%
181.51
|
173.64 | 170.87 | 146.47 | 146.09 |
| Basic Earnings Per Share |
16.44%
-0.61
|
-0.73 | -0.71 | -0.74 | -0.60 |
| Diluted Earnings Per Share |
16.44%
-0.61
|
-0.73 | -0.71 | -0.74 | -0.60 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):